Aurora kinase inhibitor CCT129202, Purity ≥98%

Cat. No.: X23-10-ZQ464

Aurora kinase inhibitor CCT129202, Purity ≥98%

Synonym: CCT129202; 942947-93-5; CCT-129202; 2-(4-(6-Chloro-2-(4-(dimethylamino)phenyl)-1H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide; CHEMBL392525; 8N349V9Q27; 2-(4-(6-Chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide; Aurora kinase inhibitor

  • CAS Number: 942947-93-5
  • Compound CID: 16202152
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
CCT129202, soluble in DMSO and insoluble in ethanol and water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A, Aurora B, and Aurora C.
Molecular Weight
497
Molecular Formula
C23H25ClN8OS
Targets
Aurora A: 42 nM; Aurora B: 198 nM; Aurora C: 227 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 3 mg/mL (6.03 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
CCT129202 can be used in examining the inhibition of Aurora kinases and its effects on tumor cells.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0